Beat The Denominator

Investors should closely monitor STRC as it struggles to maintain its $100 peg, watching for a potential yield hike to 11.75% as a signal to re-enter the position. Bitcoin (BTC) remains under short-term pressure due to conference-related sentiment and macro headwinds, with a key support level to watch near $76,000. Expect significant volatility across the NASDAQ as Microsoft (MSFT), Amazon (AMZN), Meta (META), and Alphabet (GOOGL) report earnings with a heavy focus on AI CapEx spending. High Oil prices approaching $100 and geopolitical tensions are driving a broader "risk-off" environment, making defensive positioning favorable until Federal Reserve Chair Jerome Powell provides further clarity. Avoid speculative assets like Nakamoto (NACA) in the immediate term as short-selling rumors and negative sentiment continue to weigh on its price action.

Investors should consider the current pullback in Nebius (NBIS) to the $133 level as a high-conviction entry point, given its massive $49 billion contract backlog and projected 600% growth over the next year. Within the semiconductor space, NVIDIA (NVDA) remains the preferred play over AMD due to its superior profit margins and a valuation that suggests a path toward a $10 trillion market cap by 2030. While the broader AI sector is taking a "breather" following reports of slowing growth at OpenAI, this volatility creates a buying opportunity for high-growth companies with low valuation multiples. For those seeking stability, Tesla (TSLA) is currently showing steady consolidation, acting as a stabilizing force compared to the more volatile AI and software sectors. Finally, investors in Bitcoin (BTC) and miners like MicroStrategy (MSTR) should prepare for continued correlation with growth stocks, as miners increasingly pivot their infrastructure to support AI workloads.

Investors should consider MicroStrategy (MSTR) as a high-conviction play on Bitcoin (BTC), especially as its MNAV premium has dipped to a more attractive entry point of 1.25. The company is aggressively using its equity program to accumulate BTC, aiming to drive a Bitcoin Yield that could reach 20% by 2026. For direct Bitcoin exposure, ignore short-term weekend volatility and "liquidation hunts" which are designed to wipe out high-leverage traders. Avoid using leverage above 2x on platforms like Hyperliquid or Binance, as even a minor 2.5% price swing can result in a total loss of capital. Focus on the long-term institutional strategy of increasing Bitcoin per share rather than reacting to the "noise" of retail-driven liquidations.

Investors should view Bitcoin (BTC) as a primary hedge against long-term inflation, especially as it consolidates near $78,000 before an expected move higher. MicroStrategy (MSTR) remains the highest-conviction play for leveraged Bitcoin exposure, as the company aggressively uses equity offerings to accumulate more tokens. For those seeking income, Strategy Shares (STRC) offers a transparent yield-generating strategy that captures the "delta" between Bitcoin's growth and fund payouts. Monitor the potential appointment of Kevin Warsh as Fed Chair, as a shift toward "dovish" lower interest rates would serve as a massive tailwind for risk assets. While AI stocks may require a short-term breather after a rapid rally, the sector continues to provide long-term value through disruptive marketing and operational efficiencies.

Investors should consider Hyperliquid (HYPE) as a high-conviction play on the secular shift from centralized to decentralized exchanges, benefiting from a deflationary "buyback" mechanism that uses 99% of trading fees to support the token price. For those restricted by US regulations or seeking traditional brokerage access, the stock PURR serves as a Digital Asset Treasury that holds HYPE as its primary asset and currently trades near its net asset value. While Solana (SOL) remains a major competitor, HYPE has shown significant relative outperformance due to its superior fee-burning model and dominant position in the perpetual futures market. This sector represents the "evolution of finance," but investors must be aware that these assets are high-risk and subject to extreme volatility. For long-term exposure, PURR offers a unique advantage by allowing investors to use their position as collateral within the traditional financial system while capturing the growth of the Hyperliquid ecosystem.

Accumulate Tesla (TSLA) during recent price dips as a long-term core holding, but avoid short-term options or LEAPS due to unpredictable delivery timelines. Nebius (NBIS) offers a unique margin of safety through its 28% stake in ClickHouse, making it a preferred play in the AI cloud sector with a target consolidation range of $130 to $150. Hims & Hers Health (HIMS) remains a high-conviction buy following its partnership with Eli Lilly, as the market has yet to fully price in the scale of this deal. While NVIDIA (NVDA) is justified in its recent breakout after months of sideways trading, investors should exercise caution with AMD, which appears overextended and prone to a pullback. Finally, the current price stability in Bitcoin (BTC) and MicroStrategy (MSTR) is a bullish signal, suggesting a healthy base is forming for the next leg of the market cycle.

Investors should consider MicroStrategy (MSTR) as it targets a recovery toward the $100 level, utilizing a strategy of selling equity at a premium to acquire more Bitcoin. For those seeking yield and credit exposure, STRC (MicroStrategy Preferred Equity) is rapidly scaling and can now be accessed via traditional funds like the iShares Preferred ETF (PFF) or through Solana and Ethereum DeFi protocols. Bitcoin (BTC) remains in a consolidation phase, but a breakout above $80,000 is anticipated once geopolitical tensions and oil prices stabilize. Strive (SATA) offers a secondary play on the "Bitcoin Treasury" model, having recently broken the $100 price mark through active accumulation. All these positions are high-conviction bets on Bitcoin as "digital gold," meaning they carry significant risk if the underlying crypto thesis fails.

Investors should consider Hims & Hers Health (HIMS) as a high-conviction play as it evolves into a "tech-like" platform by distributing Eli Lilly’s (LLY) blockbuster weight loss drug, Zepbound. The stock offers a potential buying opportunity due to a market disconnect where business fundamentals are improving while the price remains suppressed. HIMS captures high-margin recurring revenue through a $149 monthly membership fee, utilizing AI-powered consultations to maintain 80-90% margins. This partnership de-risks the investment by reducing legal reliance on compounded drugs and positions HIMS to cross-sell proprietary treatments for hair loss and anxiety. For long-term growth, monitor the potential H2 release of Retatrutide, which could serve as the next major catalyst for both LLY and its distribution partners.

Investors should monitor STRETCH (STRC) as it currently trades below its $100 par value, offering a temporary entry point into a high-yield instrument backed by significant Bitcoin (BTC) collateral. Management’s shift to a bi-monthly dividend schedule is a strategic move designed to stabilize the price and accelerate a recovery to the $100 level. The recent sell-off in Hims & Hers Health (HIMS) presents a buying opportunity, as the market likely overreacted to Amazon’s (AMZN) entry into the GLP-1 space. HIMS maintains a competitive advantage through its transparent, bundled pricing model, which contrasts with the complex, insurance-heavy traditional healthcare approach adopted by Amazon. Use the current "risk-off" market volatility driven by geopolitical news to accumulate these high-conviction assets while they are disconnected from their fundamental value.

Celsius Holdings (CELH) presents a high-conviction contrarian opportunity as the stock trades near year-to-date lows despite projected 40% revenue growth and elite 51% gross margins. Investors should view the current price near $33 as a "dirt cheap" entry point for a brand that is successfully replacing coffee for Gen Z and outperforming legacy competitors like Monster (MNST). Similarly, On Holding AG (ONON) is a "pure play" growth trade, with revenue tripling since its IPO while the stock price remains stagnant, offering a rare 63% gross margin in the apparel sector. Both companies currently pass the "Rule of 40" gold standard, indicating they are efficiently scaling while taking significant market share from incumbents like Nike. Focus on these two names as they trade at a significant valuation discount relative to their "cash-printing" business fundamentals and high consumer demand.

Hims & Hers Health (HIMS) is currently a high-conviction growth play, with analysts suggesting the stock remains undervalued at $31–$32 despite recent volatility. Investors should look toward a long-term 2029 revenue target of $6.5 billion, driven by the company's expansion into the massive GLP-1 weight loss and peptide markets. For those seeking Bitcoin exposure with less operational complexity than telehealth, MicroStrategy (MSTR) remains a top-three recommended vehicle for tracking digital asset growth. Expect Tesla-like price swings in HIMS, as its "no-insurance" model and AI-driven MedMatch technology disrupt traditional pharmacy and healthcare distribution. This "direct-to-consumer" healthcare theme is particularly strong for capturing Gen Z users who prioritize transparent, upfront pricing over traditional insurance co-pays.

Investors seeking leveraged exposure to Bitcoin should prioritize MicroStrategy (MSTR) over traditional ETFs, as the company’s aggressive "BTC Yield" strategy actively increases the amount of BTC held per share. MSTR is currently utilizing its At-The-Market (ATM) equity offering to raise capital at a premium, a move that is accretive to shareholders and could drive a 20% increase in Bitcoin-per-share by year-end. While short-term volatility from recent short-seller attacks may persist for 7 to 10 days, this provides a strategic entry point before the market's focus shifts back to the company's massive capital raises. For Bitcoin itself, expect a period of healthy consolidation and flat price action near the $75,000 level as the market washes out "Extreme Greed" following geopolitical noise. Use any "small down days" in the immediate future to accumulate positions in BTC or MSTR before the next inevitable leg of the rally begins.

Investors should monitor MicroStrategy (MSTR) for a potential catalyst announcement regarding a massive 30,000 BTC purchase, though caution is advised as the stock currently trades at a high 26% premium to its holdings. For those seeking income, STRC is transitioning to a semi-monthly dividend schedule to reduce price volatility and combat negative market sentiment. Bitcoin (BTC) has established a new base near $78,000, but traders should remain alert to geopolitical tensions in the Middle East which continue to drive short-term price swings. A "barbell strategy" is recommended for balanced exposure, holding BTC directly for growth while using yield-bearing instruments like STRC for cash flow. Avoid chasing the recent 35% rally in MSTR at current levels, as the market enters a "basing" period to solidify recent gains.

Investors should prioritize Bitcoin (BTC) as a primary growth engine, targeting an expected annualized return of 29% as it transitions into a superior corporate treasury collateral. For risk-managed exposure, Strive (ASST) offers a high-upside play on Bitcoin while utilizing a cash buffer to maintain monthly dividends even during market drawdowns. Consider Stretch (STRC) as a "cash-plus" alternative for treasury diversification, offering an 11.5% yield backed by math and code rather than traditional banking IOUs. Monitor MicroStrategy (MSTR) for a potential shift of its $2.25 billion cash reserve into Bitcoin-linked yield instruments as the market for decentralized collateral matures. To mitigate sovereign and banking risk, investors should diversify away from traditional checking accounts toward assets backed by Bitcoin to avoid the vulnerabilities of the zero-reserve fractional banking system.

Investors seeking high-yield income with lower volatility than Bitcoin should consider MicroStrategy preferred-style instruments STRC and SEDA, which currently offer yields of 11.5% and 13% respectively. By holding a combined portfolio of approximately 58% STRC and 42% SEDA, you can create a consistent weekly dividend stream to fund expenses or accelerate compounding. Starting in June, STRC will transition to bi-monthly payouts on the 1st and 15th, while SEDA is expected to pay on the 7th and 21st. This shift to more frequent distributions is designed to reduce price drawdowns on ex-dividend dates, potentially making these assets eligible for "Low Volatility" ETFs like PFF. While these assets are available on platforms like Schwab and Robinhood, investors should note they currently carry a 50% maintenance margin and are not yet treated as "pristine collateral" like Treasuries.

Bitcoin (BTC) is currently viewed as undervalued with a recovery phase just beginning; investors should consider direct exposure or high-conviction proxies like MicroStrategy (MSTR) and Bitcoin Miners to hedge against currency debasement. Hims & Hers Health (HIMS) presents a significant mispricing opportunity with a projected price target in the low $40s by 2025, though investors must be prepared for high volatility. Despite recent stagnation, NVIDIA (NVDA) remains a top pick as its fundamental AI growth outpaces its current stock price, which is still trading below pre-October levels. Tesla (TSLA) and Zoom (ZM) are highlighted as contrarian buys, with TSLA specifically noted for being 15% below recent highs despite its long-term leadership in EV and AI. To navigate the "Black Swan" environment of the 2020s, maintain high cash reserves and strictly avoid margin or complex options to survive sudden, macro-driven market swings.

Investors should consider Zoom Video Communications (ZM) as a high-conviction "hidden" AI play due to its 1.2% ownership stake in Anthropic. At a rumored Anthropic valuation of $800 billion, ZM’s stake would be worth $9.6 billion, representing nearly 40% of its total market cap and making it a more concentrated proxy for AI growth than Amazon (AMZN) or Google (GOOGL). When accounting for its $7.8 billion in cash and the value of its private AI holdings, ZM’s core business is trading at a deep-value EV/EBITDA of 6.6, which analysts suggest provides a significant margin of safety. Monitor developments regarding Anthropic’s "Project Mythos," as its potential to redefine software coding could serve as a massive valuation catalyst for minority shareholders. This creates an asymmetric risk/reward opportunity to buy a profitable, cash-rich company while gaining exposure to a leading contender for the next multi-trillion dollar AI powerhouse.

Investors should consider MicroStrategy (MSTR) as a high-beta, leveraged play on Bitcoin, as the stock is currently outperforming the underlying asset by a factor of five. While Bitcoin (BTC) is viewed as significantly undervalued at current levels, watch for institutional adoption from BlackRock (IBIT) and pro-crypto legislation to drive the next leg toward historical highs. For a tactical recovery play, the Strive Bitcoin Income & Growth ETF (STRC) is expected to rebound toward the $100 level early this week as sentiment-driven selling subsides. Maintain core high-conviction positions in growth leaders like Tesla (TSLA) and Hims & Hers Health (HIMS) as the broader market shifts back into a "risk-on" environment. Despite the current rally, avoid chasing the move with new capital and instead wait for market stability to hedge against recurring geopolitical volatility.